In DSS-induced colitis in mice, treatment with VPY, a novel PepT1-transported tripeptide derived from enzymatic hydrolysis of soy glycinin, down-regulated the expression of pro-inflammatory cytokines, reduced inflammation severity and DSS-induced colitis symptoms [46]. The gene discussed is SLC15A1; the disease is colitis.